Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.085 USD | +2.21% | -3.44% | -36.79% |
Business Summary
Number of employees: 306
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Pharmaceutical Products
100.0
%
| 211 | 100.0 % | 257 | 100.0 % | +21.89% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 211 | 100.0 % | 257 | 100.0 % | +21.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 31/08/10 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 28/02/21 |
Chief Tech/Sci/R&D Officer | - | 30/11/21 | |
Rosh Dias
CTO | Chief Tech/Sci/R&D Officer | - | 14/03/22 |
Karen Kotz
SAM | Sales & Marketing | - | 31/07/22 |
Paul Reider
PRN | Corporate Officer/Principal | 55 | 31/12/20 |
Corporate Officer/Principal | - | 27/04/14 | |
Corporate Officer/Principal | 57 | 16/12/21 | |
Rebecca Sunshine
HRO | Human Resources Officer | 61 | 31/12/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 04/01/21 |
Mats Wahlström
BRD | Director/Board Member | 70 | 31/12/11 |
Ali Satvat
BRD | Director/Board Member | 46 | 30/04/14 |
Lee Newcomer
BRD | Director/Board Member | 71 | 01/02/22 |
Denny Lanfear
CEO | Chief Executive Officer | 68 | 31/08/10 |
Georgia Erbez
BRD | Director/Board Member | 57 | 02-19 |
Director/Board Member | 68 | 17/05/22 | |
Michael Ryan
BRD | Director/Board Member | - | 17/07/23 |
Director/Board Member | 56 | 29/07/20 | |
Charles Newton
BRD | Director/Board Member | 53 | 04/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 113,498,415 | 108,865,391 ( 95.92 %) | 0 | 95.92 % |
Company contact information
Coherus BioSciences, Inc.
333 Twin Dolphin Drive Suite 600
94065, Redwood City
+650 649 3530
http://www.coherus.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.79% | 232M | |
-2.44% | 103B | |
+1.70% | 95.28B | |
+1.46% | 22.15B | |
-15.77% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.04% | 16.05B | |
+5.27% | 13.68B | |
+34.35% | 12.17B |
- Stock Market
- Equities
- CHRS Stock
- Company Coherus BioSciences, Inc.